GlassScriptPhysician profile
Beverly Jucknath
NPI 1235693268
$10,337.69
in general payments reported to CMS, 2019-2025
23 companies · $2,305 in 2025
The $2,305 reported for 2025 was more than what 95% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $582 · 2022: $4,240 · 2023: $2,762 · 2024: $448 · 2025: $2,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,767 · Food and Beverage: $2,658 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,766.88 |
| Food and Beverage | $2,658.46 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $3,095.94 | 2022-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Atricure, INC. | $2,289.78 | 2025 | Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Medtronic, INC. | $2,287.83 | 2021-2023 | Corevalve Evolut R |
| Abiomed | $499.58 | 2022-2023 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $303.06 | 2021-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $245.57 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $240.23 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $236.50 | 2022 | |
| Boston Scientific Corporation | $163.31 | 2022-2023 | Resonate El Icd Vr |
| Pfizer INC. | $132.15 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $124.95 | 2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $123.84 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $115.91 | 2021 | |
| Penumbra, INC. | $113.59 | 2023 | Indigo System |
| Teleflex LLC | $106.15 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.08 | 2024 | Lifevest |
| Merck Sharp & Dohme LLC | $41.13 | 2022-2023 | Verquvo |
| Akcea Therapeutics, INC. | $24.32 | 2021 | |
| Kestra Medical Technology Services, INC. | $24.29 | 2024 | Assure Wcd |
| Shockwave Medical, INC | $23.53 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Scpharmaceuticals INC. | $15.90 | 2024 | |
| Vital Connect, INC | $15.59 | 2025 | Vitalpatch Rtm |
| Amgen INC. | $15.46 | 2024 | Repatha |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beverly Jucknath listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.